MENU 简体中文ENG
About Us
About Us

OBiO Tech is committed to becoming a global leader in gene and cell therapy CRO and CDMO to serve our customers worldwide with the best possible. We provide holistic research, development, manufacturing solutions, functional genomics, process and analytical development, IND-enabling CMC, clinical and commercial manufacturing expertise, capabilities, and compliance. Our missing is to "Enable gene therapy for a better life" through quality service to help advance advanced therapeutic products to clinics and manufacturing.

OBiO Tech is built upon ten years of industry experience, focusing only on bringing gene and cell therapies to the next level. Thanks to years of trust and recognition from our customers, by April 2023, as a quality service provider, we have supported over 150 gene and cell therapy programs, of that 25 programs have been approved for clinical trials in the US and China.

OBiO's current services with scale include plasmids, mRNA, AAV vector, oncolytic virus, immuno cell therapy, stem cells, etc. With the newest and largest cGMP facilities in production in the Asian Pacific, we can provide unparalleled skills and capabilities to bring success to more clients worldwide.

History
2013
  • Founding of OBiO Technology (Shanghai) Corp., Ltd.
2014
  • Embarked on contract research services for gene therapy
  • Acquisition of Neuron Biotech, establish a leading position in contract research services of adeno-associated virus in China
2015
  • Series A financing completed
  • Industry-academia-research strategic collaboration with Chinese Academy of Medical Sciences (CAMS)
2016
  • Started the operation of research and development platform at SPIRO Site
  • Listed on National Equities Exchange and Quotations (NEEQ)
2017
  • Constructed and started operating the GLP pilot platform for viral vector at SPIRO Site
  • Global strategic collaboration with GE Healthcare on gene therapy
2018
  • First Pre-IND project of viral vector product
2019
  • Operation started at PINE Site with +5,000 sqm GMP footprint
  • Delisted from National Equities Exchange and Quotations (NEEQ)
  • Official registration of OBiO Intelli-M manufacturing site
2020
  • Completion of four rounds of financing
  • Scaled up to +7,000 sqm GMP footprint
  • Third-party GMP audit clearance
  • Supported the first oncolytic virus IND clearance in China, the United States and Australia
  • Embarked on the construction of OBiO Intelli-M at Lin-Gang Free-Trade Zone
2021
  • Successful IPO submission on STAR Board
  • Scaled up to +10,000 sqm GMP footprint
  • Supported multiple Phase II clinical studies
  • Initiation of AAVneO™ capsid screening platform with novel serotypes obtained
2022
  • Successful Listing on Shanghai Stock Exchange (SSE, code: 688238)
2023
  • The OBiO Intelli-M cGMP GCT manufacturing facility is now officially operational and fully operational.
Future
  • For Global Customer Becoming a leading multi-service provider in biopharmaceutical industry
Our Facilities
As a trustful contract development and manufacturing organization, flexible capacities and regulatory compliant facilities are the prerequisites for providing high-quality services to gene and cell therapy developers. To offer services to worldwide customers, we have established an integrated research platform with over 5,000 sqm footprint, over 10,000 sqm GMP footprint at Shanghai International Medical Park, and a 77,000 sqm GMP manufacturing site at Lin-Gang Free-Trade Zone. We provide high-quality contract research and manufacturing services at three locations:
Leadership Team
OBiO is led by an experienced team of executives. Their professional background and cumulative expertise provide robust support for strong leadership that keeps OBiO at the frontier of the gene therapy industry.
CONTACT US
First Name*
Last Name*
Company*
Email*
Phone Number*
I'm interested in…
Questions or Comments
Security Code*
I AGREE*
By submitting this form I agree that OBiO may process my data in the manner described in OBiO’s Privacy Policy
We won’t share your information.
Events
© 2023 OBiO Tech, Inc. All Rights Reserved